The new AI chatbot of the Evie ring has been trained exclusively with medical journals.

At the CES 2025 event, artificial intelligence has taken a prominent role in health technology, highlighting various applications such as algorithms, health recommendations, and chatbots. However, AI is also known for generating erroneous content, which is concerning in the healthcare sector, where accuracy and privacy are essential. In this context, the company Movano has emphasized that its new chatbot, EvieAI, has been trained exclusively using peer-reviewed medical journals.

EvieAI presents itself as a more accurate alternative to generative AI assistants like ChatGPT, as it will not pull information from large public databases where misinformation about health and wellness can proliferate. According to John Mastrototaro, CEO of Movano, this chatbot has been specifically trained with data from over 100,000 medical journals written by industry professionals. The information accessible to EvieAI comes only from accredited sources that have been reviewed by a medical board, including journals and procedures approved by the FDA.

This limited language model (LLM) is based on medical data, which is cross-referenced with information from recognized institutions such as Mayo Clinic, Harvard, and UCLA to ensure consistency and avoid discrepancies in its responses. Movano claims that EvieAI achieves 99% accuracy, although it was not possible to verify this before the event. The operation consists of EvieAI analyzing whether what is offered in the conversation is consistent with the data it has been trained on every time it is queried.

Despite the ambition to achieve a high level of accuracy, delivering precise information is not common in most chatbots. Movano has committed to ensuring that EvieAI will only respond when it has correct information to provide. If it does not know the answer, EvieAI will communicate this to the user, thus addressing the tendency of other systems to provide misleading information.

This chatbot is designed to be a conversational resource focused on providing clear answers to questions about health and wellness, with particular attention to women's health. However, the field of health is constantly changing, and peer-reviewed research can offer contradictory findings. For this reason, Movano has decided that EvieAI will not engage in diagnostics and will instead act as a guide that poses clarifying questions to direct users in their search for information.

Additionally, if critical situations arise, such as severe symptoms, EvieAI will redirect users to emergency services. This tool is expected to help users better prepare for medical visits, avoiding getting lost in informational mazes that other platforms sometimes present.

Regarding privacy, Movano guarantees that EvieAI will comply with industry encryption standards both for data storage and transmission, and that conversations will not be associated with personal identifiers. It will also ensure the periodic deletion of conversational information without it being used for targeted advertising.

Movano has demonstrated a firm commitment to medical best practices and has recently obtained FDA approval for its EvieMED ring, dedicated to remote patient monitoring. Additionally, the company aims to incorporate health data collected from its devices in the future. A beta version of EvieAI is set to be launched for Evie Ring users at no additional cost on January 8th.